| Founded | 2010, Qingdao, China |
|---|---|
| Global Reach | 100+ countries |
| Certifications | GMP, FDA VMF, CEP, ISO |
| Core Products | UDCA, veterinary APIs, antibiotics, nutrition ingredients |
| India-Specific | DMF/CEP support, competitive pricing |
India's pharmaceutical industry generated an estimated USD 66 billion in 2024, with the domestic market projected to reach USD 130 billion by 2030. The country is the world's third-largest pharmaceutical producer by volume, with over 3,000 drug companies and 10,500+ manufacturing units. Indian pharma exports reached USD 30.47 billion in FY 2024-25, growing 9.4% year-on-year. As India's generic drug industry scales, reliable API supply chains from qualified Chinese manufacturers have become a strategic necessity.
KingWish has served Indian pharmaceutical manufacturers since 2010. We understand the specific requirements of the Indian market: competitive pricing structures that allow generics manufacturers to maintain margins, regulatory documentation tailored to CDSCO ANDA filings, and logistics routes optimized for Indian port infrastructure. Unlike commodity API traders, KingWish operates with full GMP certification, active FDA VMF and CEP filings, and an in-house regulatory affairs team that handles DMF preparation, deficiency letter responses, and stability data compilation. Our Shandong-based quality control laboratory tests every batch against pharmacopoeia monographs before shipment, reducing the risk of import testing failures at Indian ports.
Indian generic manufacturers cover 60 therapeutic categories and produce over 60,000 branded generics. KingWish's product portfolio aligns with the highest-demand API categories for Indian formulators.
KingWish is China's largest UDCA supplier. UDCA is the standard-of-care for Primary Biliary Cholangitis (PBC), with growing demand from Indian hepatology and gastroenterology formulations. We supply USP/EP-grade UDCA with full DMF documentation for ANDA filings.
Spectinomycin HCl, amoxicillin trihydrate, tilmicosin phosphate, gentamycin sulphate, and azithromycin dihydrate. India's poultry and livestock sectors are among the world's largest, driving consistent demand for veterinary antibiotic APIs.
Amoxicillin trihydrate, ampicillin trihydrate, azithromycin dihydrate, and amikacin sulphate. India produces 20% of the global generic drug supply by volume, and antibiotic APIs form a large share of that output.
Food and feed-grade additives including amino acids, vitamins, and mineral premixes. India's nutraceutical market is growing at over 20% CAGR, creating demand for imported nutrition ingredients.
Market context: India currently imports approximately USD 8.9 billion in pharmaceutical inputs annually. China is India's largest API supplier, accounting for roughly two-thirds of bulk drug imports. Indian API imports are projected to reach USD 12 billion by 2030, driven by the Production Linked Incentive (PLI) scheme's focus on domestic manufacturing expansion. KingWish is positioned to grow with this demand, offering GMP-certified APIs at pricing structures that work for India's cost-sensitive generic drug market.
The Central Drugs Standard Control Organization (CDSCO) oversees pharmaceutical regulation in India. For Indian manufacturers filing Abbreviated New Drug Applications (ANDAs) or marketing authorization applications, the API supplier's regulatory documentation is a critical component of the submission package.
We prepare Drug Master Files in CTD format with Module 3 CMC data, including manufacturing process descriptions, impurity profiles, stability studies (ICH Q1A), method validation, and specifications. Both open and closed DMFs available.
KingWish holds active CEP certifications recognized by Indian regulatory authorities. For APIs covered by a CEP, the ANDA filing process is simplified — the CEP serves as pre-reviewed quality documentation.
Our regulatory team responds to CDSCO deficiency letters and technical queries within agreed timelines. We maintain a library of standard responses for common queries regarding residual solvents, genotoxic impurities, and stability data.
All KingWish APIs are manufactured under ICH Q7 GMP conditions. We provide GMP certificates, site master files, and quality agreements tailored to Indian regulatory requirements. Our facilities are auditable by Indian manufacturer QA teams.
For Indian buyers, we accept payment via T/T (telegraphic transfer) and Letter of Credit through major Indian banks. Minimum order quantities vary by product — contact us for specifics. We also offer sample quantities (50-100g) for initial quality evaluation and method development prior to commercial orders.